(19)
(11) EP 4 798 720 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24808559.9

(22) Date of filing: 25.10.2024
(51) International Patent Classification (IPC): 
C12N 15/117(2010.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/117; C12N 2310/17; C12N 2310/18; C12N 2310/344; C12N 2310/315; C12N 2310/3231; C12N 2310/3515; C12N 2310/3527; C12N 2310/321; C12N 2310/322
 
C-Sets:
  1. C12N 2310/321, C12N 2310/3521;
  2. C12N 2310/322, C12N 2310/3533;
(86) International application number:
PCT/EP2024/080226
(87) International publication number:
WO 2025/088117 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 25.10.2023 EP 23205742

(71) Applicant: Rheinische Friedrich-Wilhelms-Universität Bonn
53113 Bonn (DE)

(72) Inventors:
  • HARTMANN, Gunther
    53113 Bonn (DE)
  • WUEBBEN, Christine
    53125 Bonn (DE)
  • LUDWIG, Janos
    53127 Bonn (DE)

(74) Representative: Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB 
Ganghoferstraße 68 B
80339 München
80339 München (DE)

   


(54) RIBONUCLEIC ACID CONSTRUCT CAPABLE OF INDUCING AN IMMUNE RESPONSE, AS WELL AS PHARMACEUTICAL COMPOSITION AND KIT COMPRISING SAME